Becton Dickinson stock gains on strong results and a Hold view
Published on 09/03/2026 at 18:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Becton Dickinson stock (ISIN US0718131099) traded at USD 187.58, up 0.39 percent, and sat near its 52-week high of USD 193.07 on September 3, 2026. The market value stood at USD 51.69 billion, according to MarketBeat.
August 6 still drives the story
On August 6, 2026, the company reported quarterly revenue of USD 4.98 billion and EPS of USD 3.23, both above estimates of USD 4.89 billion and USD 3.14, respectively. Revenue rose 5.4 percent from the same quarter last year, when EPS was USD 3.68.
That combination leaves the valuation in sharp relief. The share price is close to the top of the 52-week range, while the latest quarter also showed a net margin of 4.52 percent and return on equity of 14.79 percent.
Consensus stays cautious
MarketBeat says analysts currently rate Becton Dickinson as Hold, with eight Buy ratings, eight Hold ratings and one Sell rating. The same source puts the average target price at USD 187.67, almost identical to the latest quote.
The FY 2026 guidance was set at EPS of USD 12.620 to USD 12.720, and MarketBeat says analysts expect USD 12.67 for the current fiscal year. That gap is narrow, which makes the next update on execution more important than the last move in the stock.
Becton Dickinson quarterly numbers at a glance
The latest quarter and the FY 2026 outlook frame the stock after the recent move toward the upper end of its range.
Hazardous drug data gets attention
Finance Yahoo reported on September 3, 2026 that Becton Dickinson became a founding sponsor of a new medicinal hazard data standardization consortium focused on hazardous drug information. For a company built on medical devices, laboratory equipment and diagnostic products, that keeps the product mix tied to data, compliance and hospital workflows.
Price near the top
As of September 3, 2026, Becton Dickinson stock was priced at USD 187.58, with a market capitalization of USD 51.69 billion and a 52-week range from USD 127.59 to USD 193.07. The stock closed September 1, 2026 at USD 187.12, so the latest quote remained close to that level.
Becton Dickinson stock facts
- Company: Becton Dickinson and Company
- ISIN: US0718131099
- Ticker: BDX
- Trading venue: NYSE
- Price (as of September 3, 2026): USD 187.58
- Market capitalization: USD 51.69 billion (as of September 3, 2026)
- Sector / Industry: Health Care / Medical Instruments & Supplies
- Index membership: S&P 500
